Tegmine Therapeutics
CA - South SFBiotechnology
Focus: Tegmine Therapeutics is a pre-revenue biotechnology company specializing in antibody drug discovery platforms, headquartered in South San Francisco. The company operates at the platform/enabling stage, not yet generating clinical or commercial products.
Profile data last refreshed 16h ago · AI intelligence enriched 1w ago
Open Jobs
0
About Tegmine Therapeutics
AI assessmentNot HiringNo open roles listed right now. Follow Tegmine Therapeutics to get notified when they start hiring — the background below is worth knowing for when they do.
Generated by Claude from Tegmine Therapeutics's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Data completeness
0/9 — Limited
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Open Jobs (0)
No open positions listed yet. Check their careers page directly.
Help build intelligence for Tegmine Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.